Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatric Participants With IgG4-RD
Clinical trial NCT07222553 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07222553
- Sponsor
- Amgen
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-31
- Primary completion
- 2031-06-10
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.